Share this post on:

II International AIDS Conference 183 July. Vienna, Austria; 2010. 7. Cates W Jr: Soon after CAPRISA 004: time for you to re-evaluate the HIV lexicon. Lancet 2010, 376:49596. eight. Facts 001 Study. http://www.facts-consortium.co.za/page_id=83. 9. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, Taljaard M, Piper J, Gomez-Feliciano K, Chirenje M, VOICE Study Team: Pre-exposure Prophylaxis for HIV in Ladies: Everyday Oral Tenofovir, Oral Tenofovir/Emtricitabine, or Vaginal Tenofovir Gel inside the VOICE Study (MTN 003). In 20th Conference on Retroviruses and Opportunistic Infections; March three. Atlanta, Georgia, USA; 2013. ten. B nighausen T, Bloom DE, Humair S: Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A 2012, 109:212711276. 11. Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Pillay-van-Wyk V, Mbelle N, Van Zyl J, Parker W, Zungu N, et al: South African national HIV prevalence, incidence, behaviour and communication survey.Annonacin web A turning tide amongst teenagers.Turkesterone In Vitro Cape Town: HSRC Press; 2009. 12. Shisana O, Rehle T, Simbayi L, Parker W, Zuma K, Bhana A, Connolly C, Jooste S, Pillay V: South African National HIV Prevalence. Behaviour and Communication Survey: HIV Incidence; 2005. 13. Dunkle K, Beksinka M, Rees H, Ballard R, Htun Y, Wilson ML: Risk things for HIV infection amongst sex workers in Johannesburg, South Africa. Int J STD AIDS 2005, 16:25661. 14. RHRU: Reproductive Overall health Study Unit Behavioural Sentinel Survey Data Report – Consumers of loved ones arranging – Gauteng. Johannesburg, South Africa: Reproductive Well being Study Unit, University with the Witwatersrand; 2000.PMID:23439434 15. Watts C, Foss A, Kumaranayake L, Cox A, Terris-Prestholt F, Vickerman P: Identifying optimal approaches for microbicide distribution in India and South Africa: Modelling and cost-effectiveness analyses. In International Partnership for Microbicides with the London College of Hygiene and Tropical Medicine. Brussels and London; 2008. 16. Rees H: Service Delivery and Demand Challenges in Introducing new wellness merchandise. Mexico City: Microbicide Access Forum; 2008. 17. Department of Overall health Medical Study Council, OrcMacro: South Africa Demographic and Health Survey 2003. Pretoria: Department of Well being Republic of South Africa; 2007. 18. Heise L, Watts C, Foss A, Vickerman P, Trussell J, Hayes R, McCormack S: Apples and oranges Interpreting success in HIV prevention trials. Contraception 2011, 83:105. 19. Vickerman P, Foss A, Watts C: Making use of modeling to explore the degree to which a microbicide’s sexually transmitted infection efficacy may possibly contribute for the HIV effectiveness measured in phase 3 microbicide trials. J Acquir Immune Defic Syndr 2008, 48:46067. 20. Vickerman P, Watts C, Delany S, Alary M, Rees H, Heise L: The value of context: model projections on how microbicide effect might be impacted by the underlying epidemiologic and behavioral predicament in two African settings. Sex Transm Dis 2006, 33:39705. 21. Vickerman P, Foss AM, Pickles M, Deering K, Verma S, Demers E, Moses S, Alary M, Boily M-C: Is definitely the Indian HIV epidemic driven by commercial sex A modelling analysis from south India. AIDS 2010, 24:2563572.Abbreviations ART: Antiretroviral therapy; CI: Self-assurance interval for information estimates; Crl: Credibility interval for model projections defined as the 2.five to 97.five percentile variety; DALY: Disability adjusted life year; DfID: Department for International Development; FSW: Female sex workers; HIV: Human immunodeficiency viru.

Share this post on:

Author: M2 ion channel